Microbiome Therapeutic and Diagnostic Innovations

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This Genetic Technology TOE depicts trends across microbiome therapeutic and diagnostic innovations. The corresponding diagnostic segment scenario is depicted, along with the industry interactions.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through technology transfer, joint ventures, and acquisitions. The complete gamut of genetic technology applications is covered including the latest developments in omics technologies; genetic, cellular, and alternative therapies; sequencing technologies; and genetically altered animals and plants. The Health & Wellness clu

Table of Contents

Microbiome Therapeutic and Diagnostic InnovationsTechnology ProfilesPhase 2 Ecobiotic® Drug Could Treat for Clostridium Difficile Infection Microbiome to Medicine Companies are Pioneering Novel Drug Leads Microbiome Tool for Better Understanding of Disease MechanismsBacterial Profiling Test That Gives Clarity On Human Microbiota AppendixMicrobiome Industry – Diagnostic Segment Outlook Partial List of Key Players Across Microbiome Industry Industry Interactions

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.